AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G184-G191, 2008. First published November 8, 2007; doi:10.1152/ajpgi.00348.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/G184    most recent
00348.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cepinskas, G.
Right arrow Articles by Potter, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cepinskas, G.
Right arrow Articles by Potter, R. F.

INFLAMMATION/IMMUNITY/MEDIATORS

Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice

Gediminas Cepinskas, Kazuhiro Katada, Aurelia Bihari, and Richard F. Potter

Centre for Critical Illness Research, Lawson Health Research Institute, London, Ontario, Canada

Submitted 31 July 2007 ; accepted in final form 5 November 2007

Recent studies suggest that exogenously administered CO is beneficial for the resolution of acute inflammation. In this study, we assessed the role of CO liberated from a systemically administered tricarbonyldichlororuthenium-(II)-dimer (CORM-2) on modulation of liver inflammation during sepsis. Polymicrobial sepsis in mice was induced by cecal ligation and perforation (CLP). CORM-2 (8 mg/kg iv) was administered immediately after CLP induction, and neutrophil [polymorphonuclear leukocyte (PMN)] tissue accumulation, activation of transcription factor, NF-{kappa}B, and changes in adhesion molecule ICAM-1 expression (inflammation-relevant markers) were assessed in murine liver 24 h later. In addition, the effects and potential mechanisms of CORM-2-released CO in modulation of vascular endothelial cell proinflammatory responses were assessed in vitro. To this end, human umbilical vein endothelial cells (HUVEC) were stimulated with LPS (1 µg/ml) in the presence or absence of CORM-2 (10–100 µM) and production of intracellular reactive oxygen species (ROS), (DHR123 oxidation) and NO (DAF-FM nitrosation) and subsequent activation of NF-{kappa}B were assessed 4 h later. In parallel, expression of ICAM-1 and inducible NO synthase (iNOS) proteins along with PMN adhesion to LPS-challenged HUVEC were also assessed. Induction of CLP resulted in increased PMN accumulation, ICAM-1 expression, and activation of NF-{kappa}B in the liver of septic mice. These effects were significantly attenuated by systemic administration of CORM-2. In in vitro experiments, CORM-2-released CO attenuated LPS-induced production of ROS and NO, activation of NF-{kappa}B, increase in ICAM-1 and iNOS protein expression and PMN adhesion to LPS-stimulated HUVEC. Taken together, these findings indicate that CO released from systemically administered CORM-2 provides anti-inflammatory effects by interfering with NF-{kappa}B activation and subsequent downregulation of proadhesive vascular endothelial cell phenotype in the liver of septic mice.

endothelial cells; oxidative stress; nitric oxide; NF-{kappa}B



Address for reprint requests and other correspondence: G. Cepinskas, Centre for Critical Illness Research, Lawson Health Research Institute, 800 Commissioners Rd. E., VRL A6-136, London, Ontario, N6A 4G4, Canada (e-mail: gcepinsk{at}uwo.ca)




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. W. Ryter and A. M. K. Choi
Heme Oxygenase-1/Carbon Monoxide: From Metabolism to Molecular Therapy
Am. J. Respir. Cell Mol. Biol., September 1, 2009; 41(3): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mizuguchi, J. Stephen, R. Bihari, N. Markovic, S. Suehiro, A. Capretta, R. F. Potter, and G. Cepinskas
CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase
Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H920 - H929.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Tsoyi, T. Y. Lee, Y. S. Lee, H. J. Kim, H. G. Seo, J. H. Lee, and K. C. Chang
Heme-Oxygenase-1 Induction and Carbon Monoxide-Releasing Molecule Inhibit Lipopolysaccharide (LPS)-Induced High-Mobility Group Box 1 Release in Vitro and Improve Survival of Mice in LPS- and Cecal Ligation and Puncture-Induced Sepsis Model in Vivo
Mol. Pharmacol., July 1, 2009; 76(1): 173 - 182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Chen, L. Guo, C. Fan, S. Bolisetty, R. Joseph, M. M. Wright, A. Agarwal, and J. F. George
Carbon Monoxide Rescues Heme Oxygenase-1-Deficient Mice from Arterial Thrombosis in Allogeneic Aortic Transplantation
Am. J. Pathol., July 1, 2009; 175(1): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Lancel, S. M. Hassoun, R. Favory, B. Decoster, R. Motterlini, and R. Neviere
Carbon Monoxide Rescues Mice from Lethal Sepsis by Supporting Mitochondrial Energetic Metabolism and Activating Mitochondrial Biogenesis
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 641 - 648.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.